| Index | Page | |
| Report ofthe trustees | ||
| Report ofthe auditors | 7-9 | |
| Statement offinancial activities | 10 | |
| Balance sheet | ||
| Cash flow statement | 12 | |
| Notes forming part ofthe financial | statements | 13-21 |
| Directors/Trustees | Directors/Trustees | Maria Dolores Manterola | Maria Dolores Manterola | (aka | Lola Manterola) - Chairman | Lola Manterola) - Chairman | Lola Manterola) - Chairman | |
|---|---|---|---|---|---|---|---|---|
| Nicola Louise Amoroso | ||||||||
| Marta Brime (Secretary ofthe | Board of | Trustees) | ||||||
| Fernando Delgado | ||||||||
| Eleonora Geraldine | Creaturo | |||||||
| Nuria Marti | ||||||||
| Diego Megia | ||||||||
| Alvaro Portanet | ||||||||
| Snigdha Singh | ||||||||
| Josefa Diaz Mercado | ||||||||
| Chris Ciauri (appointed 27 January 2022) | ||||||||
| Treasurer | Ana De Paz | |||||||
| Company | number | 7493363 | ||||||
| Registered | charity | number | 1140193 | |||||
| Registered | office | Quadrant House - Floor |
6, 4 | Thomas | More Square, | London | ||
| E1W 1YW | ||||||||
| Auditors | UHY Hacker Young, | Quadrant | House, 4 Thomas More | Square, | ||||
| London E1W 1YW | ||||||||
| Bankers | Clydesdale Bank, 88 |
Wood Street, | ||||||
| London EC2V 7QQ | ||||||||
| Solicitors | Bates Wells k Braithwaite | London LLP | ||||||
| 2-6 Cannon Street, London | EC4M 6YH |
| Unrestricted | Restricted | Total | Unrestricted | Restricted | Total | |||
|---|---|---|---|---|---|---|---|---|
| funds | funds | funds | funds | funds | funds | |||
| 2021 | 2020 | |||||||
| Notes | ||||||||
| Incoming resources |
||||||||
| Income from: | ||||||||
| - Donations and legacies |
3.1 | 149,287 | 15,000 | 164,287 | 233,124 | 15,000 | 248,124 | |
| -Other trading activities | 3.2 | 1,683,198 | 1,683,198 | 790,473 | - | 790,473 | ||
| -Investments | 3.3 | 1,448 | 1,448 | 2,156 | 2,156 | |||
| Total incoming resources |
1,833,933 | 15,000 | 1,848,933 | 1,025,753 | 15,000 | 1,040,753 | ||
| Expenditure on: |
||||||||
| Raising funds: | ||||||||
| Fundraising events |
173,182 | 173,182 | 93,011 | 93,011 | ||||
| Charitable activities: |
||||||||
| Donations made |
757,845 | 15,000 | 772,845 | 475,976 | 15,000 | 490,976 | ||
| Total | 931,027 | 15,000 | 946,027 | 568,987 | 15,000 | 583,987 | ||
| Net movement in funds |
902,906 | 902,906 | 456,766 | 456,766 | ||||
| Reconciliation offunds |
||||||||
| Total funds brought | forward | 1,297,310 | - | 1,297„310 | 840,544 | 840,544 | ||
| Total funds carried | forward | 2,200,216 | — | 2,200,216 | 1,297,310 | - | 1,297,310 |
| 31December | 31December | ||||||
|---|---|---|---|---|---|---|---|
| 2021 | 2020 | ||||||
| Notes | |||||||
| Fixed assets | |||||||
| Tangible assets | 13,752 | 18,911 | |||||
| Current assets | |||||||
| Debtors | 300,742 | 116,278 | |||||
| Cash at bank | 1,953,648 | 1,171,830 | |||||
| 2,254,390 | 1,288,108 | ||||||
| Creditors: Amounts | falling due | ||||||
| within one | year | (67,926) | (9,709) | ||||
| Net current | assets | 2,186,464 | 1,278,399 | ||||
| Total assets | less current liabilities | 2,200,216 | 1,297,310 | ||||
| Net assets | 2,200,216 | 1,297,310 | |||||
| Funds ofthe | charity: | ||||||
| Unrestricted | funds | 2,200,216 | 1,297,310 | ||||
| Restricted funds | |||||||
| 2,200,216 | 1,297,310 |
| 31Dec 2021 | 31Dec 2020 | |||||
|---|---|---|---|---|---|---|
| Notes | ||||||
| Operating dk investing |
activities | |||||
| Receipts ofinterest | 1,448 | 2,156 | ||||
| Receipts ofother cash | 1,660,723 | 1,030,359 | ||||
| Payment ofcharitable | grants | (688,321) | (450,898) | |||
| Payment ofexpenses | (197,190) | (135,312) | ||||
| Depreciation charge of |
tangible assets |
5,158 | 5,158 | |||
| Increase in cash from | ||||||
| operating &investing | activities | 781,818 | 451,463 | |||
| Increase in cash | 781,818 | 451,463 | ||||
| (A) Reconciliation of |
changes in resources to net cash | |||||
| inflow from operating &investing | activities | |||||
| 2021 | 2021 | |||||
| Depreciation oftangible | fixed assets | 5,158 | 5,158 | |||
| Net incoming resources | 902,906 | 456,765 | ||||
| (Increase)/ Decrease in | debtors | (184,462) | 1,406 | |||
| Increase/ (Decrease) in | creditors | 58,216 | (11,866) | |||
| 781,818 | 451,463 | |||||
| (B) Analysis ofchanges | in cash balances during | the year | ||||
| 2021 | 2021 | |||||
| Cash at beginning ofperiod | 1,171,830 | 720,367 | ||||
| Cash at end ofperiod | 1,953,648 | 1,171,830 | ||||
| Increase in cash | 781,818 | 451,463 |
| Analysis ofstaff costs | ||
|---|---|---|
| 2021 | 2020 | |
| Salaries and Wages | 57,516 | 50,885 |
| Social Security Costs | 790 | 1,175 |
| Pensions | 1,312 | 1,129 |
| 59,618 | 53,189 |
| 4 | Analysis ofcharitable | Analysis ofcharitable | expenditure | Unrestricted | Unrestricted | funds | Restricted funds | Restricted funds | |||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Raising | Charitable | Raising | Charitable | 31Dec | |||||||
| Funds | activities | Sub-total | funds | activities | Sub-total | 2021 Total | |||||
| Year ended 31Dec 2021: | |||||||||||
| Activities undertaken | directly | ||||||||||
| Fundraising events |
142,463 | 142,463 | 142,463 | ||||||||
| Donations made: |
|||||||||||
| -CRIS Cancer France | 30,050 | 30,050 | 30,050 | ||||||||
| -CRISCancer Spain | 56,784 | 56,784 | 56,784 | ||||||||
| - Institute ofCancer Research | 586,487 | 586,487 | 15,000 | 15,000 | 601,487 | ||||||
| 142,463 | 673,321 | 815,784 | 15„000 | 15,000 | 830,784 | ||||||
| Support costs | |||||||||||
| Accountancy | 1,058 | 2,242 | 3,300 | 3,300 | |||||||
| Audit Fees | 2,116 | 4,484 | 6,600 | 6,600 | |||||||
| Employee costs | 13,189 | 47,374 | 60,563 | 60,563 | |||||||
| General office costs | 10,019 | 21,233 | 31,252 | 31,252 | |||||||
| Professional costs |
2,684 | 5,687 | 8,371 | 8,371 | |||||||
| Depreciation | 1,653 | 3,504 | 5,157 | 5,157 | |||||||
| 30,719 | 84,524 | 115,243 | 115,243 | ||||||||
| 173„182 | 757,845 | 931,027 | 15,000 | 15,000 | 946,027 |
| F | OR THE YEAR ENDE | OR THE YEAR ENDE | D 31DECE | MBER 2021 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4 | Analysis ofcharitable | expenditure | (continued) | |||||||||
| Unrestricted | funds | Restricted funds | ||||||||||
| Raising | Charitable | Raising | Charitable | 31Dec | ||||||||
| Funds | activities | Sub-total | funds | activities | Sub-total | 2020 Total | ||||||
| Year ended | 31 Dec 2020: | |||||||||||
| Activities undertaken | directly | |||||||||||
| Fundraising | events | 32,297 | 32297 | 32,297 | ||||||||
| Donations made: | ||||||||||||
| -CRIS Cancer France | 28,550 | 28,550 | 28,550 | |||||||||
| -CRIS Cancer Spain - Institute ofCancer Research |
3,350 403,998 |
3,350 403,998 |
15,000 | 15,000 | 3,350 418,998 |
|||||||
| 32,297 | 435,898 | 468, 195 | 15,000 | 15,000 | 483,195 | |||||||
| Suppottcosts | ||||||||||||
| Accountancy | 962 | 7,038 | 3,000 | 3,000 | ||||||||
| Audit Fees | 1,924 | 4,076 | 6,000 | 6,000 | ||||||||
| Employee costs | 46,420 | 9,790 | 56,210 | 56,210 | ||||||||
| General office costs | 8,545 | 18,107 | 26,652 | 26,652 | ||||||||
| Professional | costs | 1,210 | 2,563 | 3,773 | 3,773 | |||||||
| Depreciation | 1,653 | 3,504 | 5,157 | 5,157 | ||||||||
| 60,714 | 40,078 | 100,792 | 100,792 | |||||||||
| 93,011 | 475,976 | 568,987 | 15,000 | 15,000 | 583,987 |
| 5 | Tangible fixed ass | ets | ||||
|---|---|---|---|---|---|---|
| Fixtures | ||||||
| Total | ||||||
| Fittings | ||||||
| Cost or valuation: | ||||||
| At 1 January 2021 | 25,788 | 25,788 | ||||
| Additions | ||||||
| At 31December 2021 | 25,788 | 25,788 | ||||
| Depreciation: | ||||||
| At 1 January 2021 | 6,878 | 6,878 | ||||
| Charge for the year | 5,158 | 5,158 | ||||
| At 31December 2021 | 12,036 | 12,036 | ||||
| Net book value: | ||||||
| At 31December 2021 | 13,752 | 13,752 | ||||
| At 31December 2021 | 18,910 | 18,910 | ||||
| 6 | Debtors: amounts | falling | due with one year: | |||
| 31Dec 2021 | 31Dec 2020 | |||||
| f. | ||||||
| Trade Debtors | 290,842 | 104,078 | ||||
| Prepayments | 5,400 | 7,700 | ||||
| Other debtors | 4,500 | 4,500 | ||||
| 300,742 | 116,278 | |||||
| 7 | Other creditors: amounts | falling due within one year | ||||
| 31Dec 2021 | 31Dec 2020 | |||||
| f. | ||||||
| Other creditors and | accruals | 67,926 | 9,709 | |||
| 8 | Deferred Income | 31Dec 2021 | 31Dec 2020 | |||
| Deferred income is | included | within: | ||||
| Creditors due within one year | ||||||
| Deferred income at | 1 January | 2021 | 12,373 | |||
| Released from previous years | (12,373) | |||||
| Resources deferred | in the year |
| 9 | Financial | instruments | 31Dec 2021 | 31Dec 2020 |
|---|---|---|---|---|
| Carrying | amount offinancial assets: | |||
| Debtors | 290,842 | 104,078 | ||
| Prepayments | 5,400 | 7,700 | ||
| Other debtors | 4,500 | 4,500 | ||
| 300,742 | 116,278 | |||
| Carrying | amount offinancial liabilities: | |||
| Other creditors | (67,926) | (9,709) | ||
| 232,816 | 106,569 |
| 31Dec 2021 | 31Dec 2020 | ||
|---|---|---|---|
| Within | 1 year | 21,600 | 18,900 |
| 2 —5 years | 32,400 | 54,000 | |
| 54,000 | 72,900 |
| nalysis ofc | haritable funds |
||||
|---|---|---|---|---|---|
| Balance at | Incoming | Resources | Balance at | ||
| 1Jan 2021 | resources | expended | 31Dec 2021 | ||
| f. | |||||
| Unrestricted | funds: | ||||
| General Funds | 1,297,310 | 1,833,933 | (931,027) | 2,200,216 | |
| 1,297,310 | 1,833,933 | (931,027) | 2,200,216 | ||
| Restricted funds | 15,000 | (15,000) | |||
| Total | 1,297,310 | 1,848,933 | (946,027) | 2,200,216 |
| Unrestricted | Restricted | Total | Total | |
|---|---|---|---|---|
| funds | funds | 31Dec2021 | 31Dec2020 | |
| Fixed assets | 13,752 | 13,752 | 18,911 | |
| Debtors | 300,742 | 300,742 | 116,278 | |
| Bank | 1,953,648 | 1,953,648 | 1,171,830 | |
| Creditors | (67,926) | (67,926) | (9,709) | |
| 2,200,216 | 2,200,216 | 1,297,310 |